| Literature DB >> 30323320 |
So Young Kim1, Jae-Sung Lim2, Il Gyu Kong3, Hyo Geun Choi4.
Abstract
This study aimed to explore the risk of dementia in a middle- and older-aged population with severe or profound hearing impairments. Data were collected for the Korean National Health Insurance Service-National Sample Cohort from 2002 to 2013. Participants aged 40 or older were selected. The 4,432 severely hearing-impaired participants were matched 1:4 with 17,728 controls, and the 958 profoundly hearing-impaired participants were matched 1:4 with 3,832 controls who had not reported any hearing impairment. Age, sex, income, region of residence, hypertension, diabetes mellitus, and dyslipidemia histories were matched between hearing-impaired and control groups. The crude (simple) and adjusted (age, sex, income, region of residence, dementia, hypertension, diabetes mellitus, dyslipidemia, ischemic heart disease, cerebrovascular disease, and depression) hazard ratios (HRs) of hearing impairment on dementia were analyzed using Cox-proportional hazard models. The severe hearing impairment group showed an increased risk of dementia (adjusted HR = 1.17, 95% confidence interval [CI] = 1.04-1.31, P = 0.010). The profound hearing impairment group also showed an increased risk of dementia (adjusted HR = 1.51, 95% CI = 1.14-2.00, P = 0.004). Both severe and profound hearing impairments were associated with elevated the risk of dementia in middle- and older-aged individuals.Entities:
Mesh:
Year: 2018 PMID: 30323320 PMCID: PMC6189102 DOI: 10.1038/s41598-018-33325-x
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
General Characteristics of Participants.
| Characteristics | Severe hearing impairment | Profound hearing impairment | ||||
|---|---|---|---|---|---|---|
| Hearing impairment | Control group | P-value | Hearing impairment | Control group | P-value | |
| Follow-up (months, mean [standard deviation]) | 88.61 (±40.85) | 88.95 (±41.14) | 1.000 | 124.05 (±31.35) | 124.74 (±31.09) | 1.000 |
| Age (years old) | 1.000 | 1.000 | ||||
| 40–44 | 264 (6.0) | 1,056 (6.0) | 119 (12.4) | 467 (12.4) | ||
| 45–49 | 327 (7.4) | 1,308 (7.4) | 107 (11.2) | 428 (11.2) | ||
| 50–54 | 395 (8.9) | 1,580 (8.9) | 105 (11.0) | 420 (11.0) | ||
| 55–59 | 536 (12.1) | 2,144 (12.1) | 125 (13.0) | 500 (13.0) | ||
| 60–64 | 701 (15.8) | 2,804 (15.8) | 132 (13.8) | 528 (13.8) | ||
| 65–69 | 754 (17.0) | 3,016 (17.0) | 126 (13.2) | 504 (13.2) | ||
| 70–74 | 686 (15.5) | 2,744 (15.5) | 115 (12.0) | 460 (12.0) | ||
| 75–79 | 487 (11.0) | 1,948 (11.0) | 77 (8.0) | 308 (8.0) | ||
| 80–84 | 210 (4.7) | 842 (4.7) | 36 (3.8) | 144 (3.8) | ||
| 85+ | 72 (1.6) | 288 (1.6) | 16 (1.7) | 64 (1.7) | ||
| Sex | 1.000 | 1.000 | ||||
| Male | 2,432 (54.9) | 9,728 (54.9) | 522 (54.5) | 2,088 (54.5) | ||
| Female | 2,000 (45.1) | 8,000 (45.1) | 436 (45.5) | 1,744 (45.5) | ||
| Income | 1.000 | 1.000 | ||||
| health aid (lowest) | 357 (8.1) | 1,428 (8.1) | 198 (20.7) | 792 (20.7) | ||
| health insurance ≤10% | 404 (9.1) | 1,616 (9.1) | 83 (8.7) | 332 (8.7) | ||
| 11–20% | 271 (6.1) | 1,084 (6.1) | 54 (5.6) | 216 (5.6) | ||
| 21–30% | 339 (7.6) | 1,356 (7.6) | 89 (9.3) | 356 (9.3) | ||
| 31–40% | 333 (7.5) | 1,332 (7.5) | 69 (7.2) | 276 (7.2) | ||
| 41–50% | 355 (8.0) | 1,420 (8.0) | 75 (7.8) | 300 (7.8) | ||
| 51–60% | 322 (7.3) | 1,288 (7.3) | 51 (5.3) | 204 (5.3) | ||
| 61–70% | 415 (9.4) | 1,660 (9.4) | 83 (8.7) | 332 (8.7) | ||
| 71–80% | 420 (9.5) | 1,680 (9.5) | 72 (7.5) | 288 (7.5) | ||
| 81–90% | 566 (12.8) | 2,264 (12.8) | 96 (10.0) | 384 (10.0) | ||
| ≥91% (highest) | 650 (14.7) | 2,600 (14.7) | 88 (9.2) | 352 (9.2) | ||
| Region of residence | 1.000 | 1.000 | ||||
| Urban | 1,778 (40.1) | 7,112 (40.1) | 334 (34.9) | 1,336 (34.9) | ||
| Rural | 2,654 (59.9) | 10,616 (59.9) | 624 (65.1) | 2,496 (65.1) | ||
| Hypertension | 1.000 | 1.000 | ||||
| Yes | 2,683 (60.5) | 10,732 (60.5) | 462 (51.8) | 1,848 (51.8) | ||
| No | 1,749 (39.5) | 6,996 (39.5) | 496 (48.2) | 1,984 (48.2) | ||
| Diabetes Mellitus | 1.000 | 1.000 | ||||
| Yes | 1,274 (28.7) | 5,096 (28.7) | 188 (19.6) | 752 (19.6) | ||
| No | 3,158 (71.3) | 12,632 (71.3) | 770 (80.4) | 3,080 (80.4) | ||
| Dyslipidemia | 1.000 | 1.000 | ||||
| Yes | 1,259 (28.4) | 5,063 (28.4) | 202 (21.1) | 808 (21.1) | ||
| No | 3,173 (71.6) | 12,692 (71.6) | 756 (78.9) | 3,024 (78.9) | ||
| Ischemic heart disease | 0.060 | 0.562 | ||||
| Yes | 503 (11.3) | 1,840 (10.4) | 83 (8.7) | 310 (8.1) | ||
| No | 3,929 (88.7) | 15,888 (89.6) | 845 (91.3) | 3,522 (91.9) | ||
| Cerebrovascular disease | <0.001* | 0.066 | ||||
| Yes | 999 (22.5) | 3,402 (19.2) | 167 (17.4) | 576 (15.0) | ||
| No | 3,433 (77.5) | 14,326 (80.8) | 791 (8.26) | 3,256 (85.0) | ||
| Depression | <0.001* | 0.291 | ||||
| Yes | 603 (13.6) | 1,724 (9.7) | 66 (6.9) | 303 (7.9) | ||
| No | 3,829 (86.4) | 16,004 (90.3) | 892 (93.1) | 3,529 (92.1) | ||
*Chi-square test, Significance at P < 0.05.
Figure 1A schematic illustration of the participant selection process that was used in the present study. Out of a total of 1,025,340 participants, 5,135 severely hearing-impaired and 1,390 profoundly hearing-impaired participants were selected. The hearing-impaired participants were matched 1:4 with a control group that did not have a diagnosed hearing impairment. Finally, 4,432 severely hearing-impaired and 17,728 control participants and 958 profoundly hearing-impaired and 3,832 control participants were included.
Crude and adjusted hazard ratios (95% confidence interval) of hearing impairment for dementia.
| Hazard ratios | Severe hearing impairment (n = 22,160) | Profound hearing impairment (n = 4,790) | ||||||
|---|---|---|---|---|---|---|---|---|
| Crude | P-value | Adjusted† | P-value | Crude | P-value | Adjusted† | P-value | |
| Dementia | 1.27 (1.13–1.43) | <0.001* | 1.17 (1.04–1.31) | 0.010* | 1.47 (1.11–1.94) | 0.007* | 1.51 (1.14–2.00) | 0.004* |
*Cox-proportional hazard regression model in hearing impairment group compared to control, Significance at P < 0.05.
†Adjusted model for age, sex, income, region of residence, hypertension, diabetes mellitus, dyslipidemia, ischemic heart disease, cerebral stroke, and depression histories.
Crude and adjusted hazard ratios (95% confidence interval) of hearing impairment for dementia in subgroup analysis according to age.
| Hazard ratios | Severe hearing impairment | Profound hearing impairment | ||||||
|---|---|---|---|---|---|---|---|---|
| Crude | P-value | Adjusted† | P-value | Crude | P-value | Adjusted† | P-value | |
| Dementia | Age < 65 years old (n = 11,115) | Age < 65 years old (n = 2,940) | ||||||
| 1.46 (1.06–2.11) | 0.020* | 1.26 (0.92–1.74) | 0.115 | 2.23 (1.19–4.19) | 0.013* | 2.34 (1.22–4.49) | 0.010* | |
| Dementia | Age ≥ 65 years old (n = 11,045) | Age ≥ 65 years old (n = 1,850) | ||||||
| 1.25 (1.10–1.41) | 0.001* | 1.16 (1.02–1.32) | 0.021* | 1.34 (0.98–1.84) | 0.063 | 1.38 (1.01–1.90) | 0.043* | |
*Cox-proportional hazard regression model in hearing impairment group compared to control, Significance at P < 0.05.
†Adjusted model for age, sex, income, region of residence, hypertension, diabetes mellitus, dyslipidemia, ischemic heart disease, cerebral stroke, and depression histories.
Figure 2The Kaplan-Meier survival analysis showed that both the groups with severe (A) and profound (B) hearing impairment demonstrated a higher cumulative rate of dementia than the control groups